Background : Acute coronary syndrome (ACS) patients are widely treated with long-term beta-blocker therapy after cardiac event. Especially for low-risk patients, the benefits of beta-blockers on
To characterize the use of sacubitril/valsartan in a group of patients with heart failure in Colombia. Follow-up study of patients with heart failure who started sacubitril/valsartan and were affiliat
ACASI Interview results without formats Study Description This study developed and adapted a culturally appropriate secondary prevention intervention for young, HIV-positive women through intervention
